163 related articles for article (PubMed ID: 36790527)
1. Ribosome dysfunction underlies SLFN14-related thrombocytopenia.
Ver Donck F; Ramaekers K; Thys C; Van Laer C; Peerlinck K; Van Geet C; Eto K; Labarque V; Freson K
Blood; 2023 May; 141(18):2261-2274. PubMed ID: 36790527
[TBL] [Abstract][Full Text] [Related]
2. Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation.
Fletcher SJ; Pisareva VP; Khan AO; Tcherepanov A; Morgan NV; Pisarev AV
RNA; 2018 Jul; 24(7):939-949. PubMed ID: 29678925
[TBL] [Abstract][Full Text] [Related]
3. SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.
Fletcher SJ; Johnson B; Lowe GC; Bem D; Drake S; Lordkipanidzé M; Guiú IS; Dawood B; Rivera J; Simpson MA; Daly ME; Motwani J; Collins PW; Watson SP; Morgan NV;
J Clin Invest; 2015 Sep; 125(9):3600-5. PubMed ID: 26280575
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Novel Ribosome-Associated Endoribonuclease SLFN14 from Rabbit Reticulocytes.
Pisareva VP; Muslimov IA; Tcherepanov A; Pisarev AV
Biochemistry; 2015 Jun; 54(21):3286-301. PubMed ID: 25996083
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous mutation SLFN14 K208N in mice mediates species-specific differences in platelet and erythroid lineage commitment.
Stapley RJ; Smith CW; Haining EJ; Bacon A; Lax S; Pisareva VP; Pisarev AV; Watson SP; Khan AO; Morgan NV
Blood Adv; 2021 Jan; 5(2):377-390. PubMed ID: 33496736
[TBL] [Abstract][Full Text] [Related]
6. Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome.
Polokhov D; Fedorova D; Ignatova A; Ponomarenko E; Rashevskaya E; Martyanov A; Podoplelova N; Aleksenko M; Mersiyanova I; Seregina E; Poletaev A; Truchina E; Raykina E; Plyasunova S; Novichkova G; Zharkov P; Panteleev M
Orphanet J Rare Dis; 2023 Apr; 18(1):74. PubMed ID: 37041648
[TBL] [Abstract][Full Text] [Related]
7. Schlafen14 Impairs HIV-1 Expression in a Codon Usage-Dependent Manner.
Valenzuela C; Saucedo S; Llano M
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675845
[TBL] [Abstract][Full Text] [Related]
8. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 signaling controls multiple steps in ribosome biogenesis.
Iadevaia V; Liu R; Proud CG
Semin Cell Dev Biol; 2014 Dec; 36():113-20. PubMed ID: 25148809
[TBL] [Abstract][Full Text] [Related]
10. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of SDF-1 receptor CXCR4 in molecularly defined forms of inherited thrombocytopenias.
Salim JP; Glembotsky AC; Lev PR; Marin Oyarzún CP; Goette NP; Molinas FC; Marta RF; Heller PG
Platelets; 2017 Sep; 28(6):602-606. PubMed ID: 28032520
[TBL] [Abstract][Full Text] [Related]
12. The gray platelet syndrome: clinical spectrum of the disease.
Nurden AT; Nurden P
Blood Rev; 2007 Jan; 21(1):21-36. PubMed ID: 16442192
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
14. c-Myc overexpression increases ribosome biogenesis and protein synthesis independent of mTORC1 activation in mouse skeletal muscle.
Mori T; Ato S; Knudsen JR; Henriquez-Olguin C; Li Z; Wakabayashi K; Suginohara T; Higashida K; Tamura Y; Nakazato K; Jensen TE; Ogasawara R
Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E551-E559. PubMed ID: 34423683
[TBL] [Abstract][Full Text] [Related]
15. Single-cell analysis of megakaryopoiesis in peripheral CD34
Bigot T; Gabinaud E; Hannouche L; Sbarra V; Andersen E; Bastelica D; Falaise C; Bernot D; Ibrahim-Kosta M; Morange PE; Loosveld M; Saultier P; Payet-Bornet D; Alessi MC; Potier D; Poggi M
J Thromb Haemost; 2023 Sep; 21(9):2528-2544. PubMed ID: 37085035
[TBL] [Abstract][Full Text] [Related]
16. Effects of marine oil-enriched diets on guinea pig megakaryocyte and platelet lipids: effects on thromboxane synthesis and platelet function.
Schick PK; Menon S; Wojenski C
Biochim Biophys Acta; 1990 Feb; 1022(1):49-56. PubMed ID: 2302402
[TBL] [Abstract][Full Text] [Related]
17. Loss-of-function mutations in
Marconi C; Di Buduo CA; LeVine K; Barozzi S; Faleschini M; Bozzi V; Palombo F; McKinstry S; Lassandro G; Giordano P; Noris P; Balduini CL; Savoia A; Balduini A; Pippucci T; Seri M; Katsanis N; Pecci A
Blood; 2019 Mar; 133(12):1346-1357. PubMed ID: 30591527
[TBL] [Abstract][Full Text] [Related]
18. [SLFN14 inhibits LINE-1 transposition activity].
Mao Y; Ding JW; Chen MS; Cen S; Li XY
Yi Chuan; 2020 Jul; 42(7):669-679. PubMed ID: 32694106
[TBL] [Abstract][Full Text] [Related]
19. miR-15a-5p regulates expression of multiple proteins in the megakaryocyte GPVI signaling pathway.
Basak I; Bhatlekar S; Manne BK; Stoller M; Hugo S; Kong X; Ma L; Rondina MT; Weyrich AS; Edelstein LC; Bray PF
J Thromb Haemost; 2019 Mar; 17(3):511-524. PubMed ID: 30632265
[TBL] [Abstract][Full Text] [Related]
20. Sustained thrombocytopenia in mice: serial studies of megakaryocytes and platelets.
Stenberg PE; Levin J; Corash L
Exp Hematol; 1990 Feb; 18(2):124-32. PubMed ID: 2303104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
